Skip to main navigation Skip to search Skip to main content

Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer

Nasser K. Altorki, R. S. Keresztes, J. L. Port, D. M. Libby, R. J. Korst, D. B. Flieder, C. A. Ferrara, D. F. Yankelevitz, K. Subbaramaiah, M. W. Pasmantier, A. J. Dannenberg

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer'. Together they form a unique fingerprint.
    Sort by

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science